Investec savages Aviva over potentially irreversible decline
Investec Bank has issued a no-holds barred research note on Aviva and suggested that the provider may be in permanent decline as it cut the insurer’s target share price from 422p to 316p and advised investors to reduce their holdings.
Under the heading of "Recovery may not occur" analyst Kevin Ryan summed-up: "In our view, halting the shrinkage of Aviva's earnings, assets and dividends has now reached a critical stage. We are not sure if the decline can be reversed."
Clearly wrong
In the research note, which tackled all parts of Aviva, including both general and life insurance, the bank accepted that it was formerly a supporter of Aviva and had previously suggested the company could return to pre-eminence but that the title of
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@insuranceage.co.uk